Comparison
2q31 1 Microdeletion Syndrome vs 11p15 4 Microduplication Syndrome C4749508
Clinical comparison between 2q31 1 Microdeletion Syndrome and 11p15 4 Microduplication Syndrome for differential diagnosis and treatment planning.
6 comparison axes
Onset
2q31 1 Microdeletion Syndrome
Variable
11p15 4 Microduplication Syndrome C4749508
0-null
Onset patterns differ
Severity
2q31 1 Microdeletion Syndrome
severe
11p15 4 Microduplication Syndrome C4749508
moderate
Different severity levels
Chronic
2q31 1 Microdeletion Syndrome
Chronic
11p15 4 Microduplication Syndrome C4749508
Chronic
Differing course
Communicable
2q31 1 Microdeletion Syndrome
No
11p15 4 Microduplication Syndrome C4749508
No
Different transmission
Body System
2q31 1 Microdeletion Syndrome
congenital
11p15 4 Microduplication Syndrome C4749508
congenital
Same/different system
Category
2q31 1 Microdeletion Syndrome
rare-disease
11p15 4 Microduplication Syndrome C4749508
genetic
Different category
Bottom line
2q31-1-microdeletion-syndrome-C4274647 and 11p15-4-microduplication-syndrome-C4749508 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 2q31 1 Microdeletion Syndrome | 11p15 4 Microduplication Syndrome C4749508 | Discriminating power |
|---|---|---|---|
| Developmental features | May include variable congenital and developmental findings; specific pattern is not established here. | Described as varied developmental features related to chromosome 11 duplication. | Low |
| Severity | Source axis labels severity as severe, but individual course is not defined. | Source data label severity as moderate and emphasize individualized assessment. | Moderate |
| Onset | Onset is listed as variable. | Onset is not reliably specified in the supplied data. | Low |
When to favor each condition
Choose 2q31 1 Microdeletion Syndrome when
A confirmed 2q31.1 deletion is reported
The chromosomal interval, not severity alone, identifies this condition.
High
Features suggest a severe congenital rare-disease pattern
This matches the supplied severity axis but still requires genetic confirmation.
Low
Family counseling needs deletion-specific interpretation
A clinician or genetics specialist should interpret the exact copy-number result.
Moderate
Choose 11p15 4 Microduplication Syndrome C4749508 when
A confirmed 11p15.4 duplication is reported
The duplicated chromosome 11 region distinguishes it from a 2q31.1 deletion.
High
Developmental features are varied and assessment must be individualized
This wording matches the supplied description.
Moderate
A congenital anomaly code such as Q89.9 is being considered
The code is nonspecific and cannot by itself confirm the syndrome.
Low
How key tests differ
| Test | 2q31 1 Microdeletion Syndrome | 11p15 4 Microduplication Syndrome C4749508 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | May show a deletion involving 2q31.1 if present. | May show a duplication involving 11p15.4 if present. | The genomic location and copy-number change are the key distinction; laboratory confirmation is required. |
| Karyotype | May miss a small deletion. | May miss a small duplication. | A normal karyotype does not exclude either micro-copy-number condition. |
| Clinical genetics review | Correlates deletion size and genes with findings. | Correlates duplication size and genes with findings. | Phenotype cannot be inferred confidently from the sparse source descriptions alone. |
Prognosis comparison
2q31 1 Microdeletion Syndrome
- Outcome
- Long-term outcome is not established from the supplied data.
- Factors
- Reported severity, exact deletion, involved genes, and associated findings may matter.
11p15 4 Microduplication Syndrome C4749508
- Outcome
- Outcome is variable and requires individualized assessment.
- Factors
- Duplication extent, involved genes, developmental findings, and supportive care may matter.
Time frame: No reliable time frame is established.
Avoid using severity labels alone to predict survival, function, or treatment response.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental difficulty | Possible, but type and severity are not established here. Varied developmental features are described. Support needs should be based on individual assessment. |
| Congenital anomalies | Congenital involvement is indicated, without a defined anomaly list. Congenital classification is indicated, with varied features. Do not assume a specific organ complication without records. |
| Long-term medical complexity | Labeled chronic and severe in source axes. Labeled chronic and moderate in source data. These labels do not predict complications for an individual. |
Patient education highlights
- HighGenetic confirmation
Ask which exact chromosomal region and copy-number change were found before accepting either syndrome name.
- HighIndividual assessment
Both conditions can vary; a clinician should interpret results alongside growth, development, and examination findings.
- MediumNot contagious
Neither condition is communicable. Inheritance and recurrence questions require genetics counseling.